AmpC β-lactamases in Escherichia coli: emergence of CMY-2–producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b–ST131

This publication has 25 references indexed in Scilit:

• Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units
  Diagnostic Microbiology and Infectious Disease, 2009
• Surveillance of Community-Based Reservoirs Reveals the Presence of CTX-M, Imported AmpC, and OXA-30 β-Lactamases in Urine Isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. Community
  Antimicrobial Agents and Chemotherapy, 2008
• The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC
  Journal of Antimicrobial Chemotherapy, 2008
• Prevalence of Plasmid-Mediated AmpC β-Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC β-Lactamase Resistance in China
  Journal of Clinical Microbiology, 2008
• The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup
  Journal of Antimicrobial Chemotherapy, 2008
• Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital
  Journal of Antimicrobial Chemotherapy, 2008
• Dissemination of Clonally RelatedEscherichia coliStrains Expressing Extended-Spectrum β-Lactamase CTX-M-15
  Emerging Infectious Diseases, 2008
• Most Escherichia coli strains overproducing chromosomal AmpC -lactamase belong to phylogenetic group A
  Journal of Antimicrobial Chemotherapy, 2007
• Rapid and Simple Determination of the Escherichia coli Phylogenetic Group
  Applied and Environmental Microbiology, 2000
• Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC
  Journal of Antimicrobial Chemotherapy, 2000